Literature DB >> 15907915

Botulinal neurotoxins: revival of an old killer.

Cesare Montecucco1, Jordi Molgó.   

Abstract

Botulinal neurotoxins (BoNTs) produced by anaerobic bacteria of the genus Clostridium are the most toxic proteins known, with mouse LD(50) values in the range of 1-5 ng/kg. They are responsible for the pathophysiology of botulism. BoNTs are metalloproteinases that enter peripheral cholinergic nerve terminals, where they cleave one or two of the three core proteins of the neuroexocytosis apparatus and elicit persistent but reversible inhibition of neurotransmitter release. Their specificity of action has made them useful therapeutic agents for many human syndromes caused by hyperactivity of cholinergic nerve terminals. Their range of clinical applications is continuously growing, and BoNT/A is being used extensively as a pharmaco-cosmetic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907915     DOI: 10.1016/j.coph.2004.12.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  91 in total

1.  Topical botulinum toxin.

Authors:  Ashley Collins; Adnan Nasir
Journal:  J Clin Aesthet Dermatol       Date:  2010-03

2.  Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.

Authors:  Nipawan Nuemket; Yoshikazu Tanaka; Kentaro Tsukamoto; Takao Tsuji; Keiji Nakamura; Shunji Kozaki; Min Yao; Isao Tanaka
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-30

3.  Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.

Authors:  Mengfei Ho; Li-Hsin Chang; Melissa Pires-Alves; Baskaran Thyagarajan; Jordan E Bloom; Zhengrong Gu; Karla K Aberle; Sasha A Teymorian; Yuka Bannai; Steven C Johnson; Joseph J McArdle; Brenda A Wilson
Journal:  Protein Eng Des Sel       Date:  2010-11-04       Impact factor: 1.650

4.  Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin.

Authors:  Marla D Swain; George P Anderson; Dan Zabetakis; Rachael D Bernstein; Jinny L Liu; Laura J Sherwood; Andrew Hayhurst; Ellen R Goldman
Journal:  Anal Bioanal Chem       Date:  2010-06-28       Impact factor: 4.142

Review 5.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

6.  SNARE tagging allows stepwise assembly of a multimodular medicinal toxin.

Authors:  Frédéric Darios; Dhevahi Niranjan; Enrico Ferrari; Fan Zhang; Mikhail Soloviev; Andreas Rummel; Hans Bigalke; Jason Suckling; Yuri Ushkaryov; Nikolay Naumenko; Anastasia Shakirzyanova; Rashid Giniatullin; Elizabeth Maywood; Michael Hastings; Thomas Binz; Bazbek Davletov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 7.  Bioterrorism and the Role of the Clinical Microbiology Laboratory.

Authors:  Elizabeth Wagar
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

8.  A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.

Authors:  Hong Fang; Wentian Luo; Jim Henkel; Joseph Barbieri; Neil Green
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

9.  Superactivation of the botulinum neurotoxin serotype A light chain metalloprotease: a new wrinkle in botulinum neurotoxin.

Authors:  Laura A McAllister; Mark S Hixon; Jack P Kennedy; Tobin J Dickerson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2006-04-05       Impact factor: 15.419

10.  Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium.

Authors:  Sicai Zhang; Francois Lebreton; Michael J Mansfield; Shin-Ichiro Miyashita; Jie Zhang; Julia A Schwartzman; Liang Tao; Geoffrey Masuyer; Markel Martínez-Carranza; Pål Stenmark; Michael S Gilmore; Andrew C Doxey; Min Dong
Journal:  Cell Host Microbe       Date:  2018-01-27       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.